IO Essentials: Welcome and History of IO

• Welcome, Christos Georgiades, MD, PhD, Johns Hopkins University
• History of IO, Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center

IO Essentials: Sponsored Content 1

Additional details to come.

IO Essentials: Sponsored Content 2

Additional details to come.

IO Essentials: Sponsored Content 3

Additional details to come.

IO Essentials: Sponsored Content 4

Additional details to come.

IO Essentials: Sponsored Content 5

Additional details to come.

IO Essentials: Study Design and Ethics in IO

Moderators: Isabel Gala Newton, MD, PhD, USCS Health and VA San Diego Healthcare System; Terence P. Gade, MD, PhD, University of Pennsylvania

• Getting Started in IO Research, Lynn Jeanette Savic, MD, Universitätsmedizin Charité Berlin
• Different Statistical Methods for Medical Research, TBD
• Ethics and Consent in IO, Isabel Gala Newton, MD, PhD, USCS Health and VA San Diego Healthcare System
• Building A Successful Mentor-Mentee Relationship, Alda Tam, MD, MD Anderson Cancer Center

Breakfast and Industry Symposium

Additional details to come. 

President's Welcome & Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture

• President's Welcome, Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
• Program Chair's Program Overview, Vijay Ramalingam, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
• Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture, Prof. Thierry de Baere, MD, Gustave Roussy Cancer Center

State-of-the-Art HCC

Moderators: Laura Crocetti, MD, PhD, EBIR, University of Pisa; Parissa Tabrizian, MD, MSc, FACS, Mount Sinai Medical Center

• Standard of Care Systemic Therapies and Pivotal Trials, Adam Burgoyne, MD, PhD, UC San Diego
• Barcelona Update and BCLC Stage Migration Issues, David C. Madoff, MD, Yale School of Medicine
• 2024 Resection and Transplantation Updates, Parissa Tabrizian, MD, MSc, FACS, Mount Sinai Medical Center
• Current Status: Locoregional Primer, Laura Crocetti, MD, PhD, EBIR, University of Pisa

Expo Hall, Lunch and Industry Symposium

Additional details to come. 

Ablation Hands-on: Image Guidance & Robotics

Moderators: Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, European Institute of Oncology (IRCCS); Marie Beerman, MD, Danderyd Hospital

• Rationale Behind Using Image Guidance and Advanced Ablation, Denis Szejnfeld, MD, PhD, Unifesp
• Basics of Stereotactic Ablation and Setting Up a Program, Iwan Paolucci, PhD, MD Anderson Cancer Center
• Stereotactic RF Ablation of the Liver: Why I Use It and the Advantages of Multiple Needles, Reto Bale, MD FCIRSE, Medical University Inssbruck
• Stereotactic Microwave Ablation of Liver Lesions, Marie Beerman, MD, Danderyd Hospital
• Putting it All Together: Treatment Planning, Guidance, and Ablation, Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, European Institute of Oncology (IRCCS)
• Hands-on Learning, All above faculty

SIO Grant Showcase

Moderator: Julius Chapiro, MD, PhD, Yale School of Medicine

• SIO Grants Overview, Julius Chapiro, MD, PhD, Yale School of Medicine
• 2022 Grant Update: Single Cell Analysis of Combined Thermal Ablation and Immunotherapy of HCC, Prof. S. Nahum Goldberg, MD, FSIR, FCIRSE, Hadassah Hebrew University Medical Center
• 2022 Grant Update: Stoking an Anti-Liver Cancer Immune Response with Cryoablation Plus Intratumoral Immunostimulant, Isabel Gala Newton, MD, PhD, UCSD Health and VA San Diego Healthcare System
• 2022 Grant Update: Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy in HCC, Kelley Weinfurtner, MD, University of Pennsylvania
• 2022 Grant Update: Engineered Extracellular Vesicles to Modulate Immunotherapy in Liver Cancer, Kiyoyuki Minamiguchi, MD, PhD, MD Anderson Cancer Center
• 2023 Grant Update, Recipient TBD
• 2023 Grant Update, Recipient TBD

HCC Tumor Board

Moderators: Riad Salem, MD, MBA, Northwestern University; Muneeb Ahmed, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School

Science and Industry Reception

Additional details to come.

Breakfast and Industry Symposium

Additional details to come. 

IO Essentials: Solid Tumor Interventions

Moderators: Christos Georgiades, MD, PhD, Johns Hopkins University; Nishita Kothary, MD, FSIR, Stanford School of Medicine

• Physics of Ablation Modalities, Christos Georgiades, MD, PhD, Johns Hopkins University
• Liver: Introduction to Ablation and Guidelines Overview, Nishita Kothary, MD, FSIR, Stanford School of Medicine
• Lung: Introduction to Ablation and Guidelines Overview, Stephen Hunt, MTR, MD, PhD, FSIR, University of Pennsylvania
• RCC: Introduction to Ablation and Guidelines Overview, Erica Alexander, MD, Memorial Sloan Kettering Cancer Center
• Radioembolization: Getting Started in Y90, Juan Gimenez, MD, Ochsner Health
• Intro to TACE and Patient Management, Zach Berman, MD, UC San Diego
• Pain Management Techniques and IO, Rahul Sheth, MD, MD Anderson Cancer Center

Scientific Oral Abstracts

Additional details to come. 

Expo Hall, Lunch and Industry Symposia

Additional details to come. Scholars may attend the symposium of their choice.

Renal/GU

Moderators: David Breen, MD, MRCP, FRCR, University Hospitals Southampton; Rodrigo Gobbo, MD, PhD, Hospital Israelita Albert Einstein

• T1A and Current Guidelines, Rodrigo Gobbo, MD, PhD, Hospital Israelita Albert Einstein
• Surgical Perspectives on Percutaneous Ablation, Pratik Kanabur, MD, UCLA
• Ablation in Patients with Chronic Renal Disease, Christos Georgiades, MD, PhD, Johns Hopkins University
• Central Renal Cancer and Ablation in Difficult Locations, Grant Schmit, MD, Mayo Clinic
• T1B Disease: What is the Current Role of IR? AJ Gunn, MD, University of Alabama at Birmingham

Must-Know Studies for MDT Tumor Board

Moderators: Phillipe Pereira, MD, SLK Kliniken GmbH Heilbronn; Rony Avritscher, MD, University of Texas MD Anderson Cancer Center; Terence P. Gade, MD, PhD, University of Pennsylvania

• The Importance of Trials and Registries in Interventional Oncology, Phillipe Pereira, MD, SLK Kliniken GmbH Heilbronn
• ACCLAIM, Constantinos T. Sofocleous, MD, PhD, FSIR, FCIRSE, Memorial Sloan Kettering Cancer Center
• IMbrave150, Adam Burgoyne, MD, PhD, UC San Diego
• LAUNCH, Lynn Jeanette Savic, MD, Universitätsmedizin Charité Berlin
• Dosisphere, S. Cheenu Kappadath, PhD, FAAPM, University of Texas MD Anderson Cancer Center

mCRC Tumor Board

Moderators: Constantinos T. Sofocleous, MD, PhD, FSIR, FCIRSE, Memorial Sloan Kettering Cancer Center; Martijn Meijerink, MD, PhD, Amsterdam UMC

Faculty: Guy Johnson, MD, PharmD, University of Washington; Yuman Fong, MD, PhD, City of Hope Medical Center; Heather McGee, MD, PhD, City of Hope Medical Group; Kimberly Perez, MD, Dana-Farber Cancer Institute/Harvard Medical School

Trivia Night

Additional details to come.

Breakfast and Industry Symposium

Additional details to come. 

IO Essentials: Preparing for Tumor Boards

Moderators: Stephen Hunt, MTR, MD, PhD, FSIR, University of Pennsylvania; Nadine Abi-Jaoudeh, MD, UC Irvine

• BCLC Immunotherapy: Current Status and Outcomes, Cristal Brown, MD, MHS, UT Austin Dell Medical School
• Liver Transplantation: Patient Selection, Anatomy, and Outcomes, Jennifer Berumen, MD, UC San Diego
• Tumor Board, All above faculty; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University General Hospital Attikon; Nishita Kothary, MD, FSIR, Stanford School of Medicine

Scientific Oral Abstracts

Additional details to come. 

Expo Hall, Lunch and Industry Symposia

Additional details to come. Scholars may attend the symposium of their choice.

Interventional Oncology and Immunotherapy

Moderators: Prof. S. Nahum Goldberg, MD, FSIR, FCIRSE, Hadassah Hebrew University Medical Center; Terence P. Gade, MD, PhD, University of Pennsylvania

• General Overview: Where Are We Currently? Gosse J. Adema, PhD, Radboud University Medical Center
• Immunotherapy and Percutaneous Ablation: What's New and Where Are We Going? Michal Mauda-Havakuk, MD, PhD, Tel-Aviv Sourasky Medical Center
• Immunotherapy and Intra-Arterial Therapy: What's New and Where Are We Going? Rony Avritscher, MD, University of Texas MD Anderson Cancer Center
• Positive Effects of Local Therapies, Prof. S. Nahum Goldberg, MD, FSIR, FCIRSE, Hadassah Hebrew University Medical Center

Oligomets Tumor Board

Moderators: David Breen, MD, MRCP, FRCR, University Hospitals Southampton; Matthew Callstrom, MD, PhD, Mayo Clinic

Faculty: Alexis Kelekis, MD, PhD, EBIR, National and Kapodistrian University of Athens; Jess Maxwell, MD, MBA, MD Anderson Cancer Center; Ann Radlow, MD, MPH, UCLA Dept. of Radiation Oncology; Sandy Liu, MD, City of Hope